https://scholars.lib.ntu.edu.tw/handle/123456789/524288
標題: | Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure | 作者: | CHO-KAI WU Luo J.-L. CHIA-TI TSAI Huang Y.-T. Cheng C.-L. JEN-KUANG LEE LIAN-YU LIN JOU-WEI LIN HWANG, JUEY-JEN FU-TIEN CHIANG |
公開日期: | 2010 | 卷: | 10 | 期: | 1 | 起(迄)頁: | 46-53 | 來源出版物: | Pharmacogenomics Journal | 摘要: | The objective of this study was to evaluate the effects of angiotensin-converting enzyme (ACE) inhibitors and pharmacogenetic interaction on the survival of the patients with diastolic heart failure (DHF). A total of 285 subjects with DHF confirmed by echocardiography were recruited in the period between 1995 and 2003. Baseline characteristics (age, sex, prior history, medication, and echocardiographic findings) and genetic polymorphisms (ACE gene insertion/deletion (I/D) polymorphism; T174M, M235T, G-6A, A-20C, G-152A, and G-217A polymorphisms of the angiotensinogen (AGT) gene; and A1166C polymorphisms of the angiotensin II type I receptor (AT1R)) were collected and matched (by propensity score) in those who received and those who did not receive ACE inhibitors. The patients were followed up to 10 years. Kaplan-Meier curves and Cox regression models were used to demonstrate the survival trend. The 85 patients who received ACE inhibitors and the other 85 patients who did not were found to have comparable baseline characteristics and polymorphism distribution. Prescription of ACE inhibitors was associated with a significant decrease in overall mortality (hazard ratio (HR), 0.45; 95% confidence interval (CI), 0.24-0.83; P0.01), and a lower rate of cardiovascular events at 4000 days (HR, 0.53; 95% CI, 0.32-0.90; P0.02). In addition, ACE I/D gene D allele was associated with higher overall mortality as compared with the I allele (HR, 2.04; P0.003). This effect was diminished in those who received ACE inhibitors. The use of ACE inhibitor was associated with a significant decrease in long-term mortality and cardiovascular events in the patients with DHF. Genetic variants in the renin-angiotensin system genes were also associated, but their effects could be modified by the use of ACE inhibitors. ? 2010 Nature Publishing Group All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-75549089270&doi=10.1038%2ftpj.2009.39&partnerID=40&md5=4656aeefacf121b6326aee0d73206aa7 https://scholars.lib.ntu.edu.tw/handle/123456789/524288 |
ISSN: | 1470-269X | DOI: | 10.1038/tpj.2009.39 | SDG/關鍵字: | aldosterone; angiotensin; angiotensin 2 receptor; angiotensinogen; beta adrenergic receptor blocking agent; calcium channel blocking agent; cytosine; digoxin; dipeptidyl carboxypeptidase; dipeptidyl carboxypeptidase inhibitor; diuretic agent; methionine; nitrate; renin; threonine; thymine; adult; aged; allele; article; controlled study; diastolic heart failure; drug efficacy; drug mechanism; echocardiography; female; gene deletion; gene insertion; genetic polymorphism; genetic variability; human; major clinical study; male; mortality; pharmacogenetics; priority journal; prognosis; renin angiotensin aldosterone system; survival; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Follow-Up Studies; Gene Deletion; Heart Failure, Diastolic; Humans; Kaplan-Meiers Estimate; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prognosis; Propensity Score; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。